CHCHD2 and Parkinson's disease

The Lancet Neurology

Volumn 14, Issue 7, 2015, Pages 680-681

  Iqbal, Zafar ^a   Toft, Mathias ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CHCHD2 GENE; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; JAPANESE (PEOPLE); LETTER; MISSENSE MUTATION; PARKINSON DISEASE; PRIORITY JOURNAL; SEGREGATION ANALYSIS; DNA SEQUENCE; FEMALE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETICS; MALE; PARKINSONISM; PROCEDURES;

MITOCHONDRIAL PROTEIN; TRANSCRIPTION FACTOR;

FEMALE; GENETIC LINKAGE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MITOCHONDRIAL PROTEINS; MUTATION, MISSENSE; PARKINSONIAN DISORDERS; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION FACTORS;

EID: 84930514782     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(15)00096-4     Document Type: Letter

References (4)

1. Funayama M, Ohe K, Amo T, et al. CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study. Lancet Neurol 2015, 14:274-282.
2. Kachergus J, Mata IF, Hulihan M, et al. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am J Hum Genet 2005, 76:672-680.
3. Healy DG, Falchi M, O'Sullivan SS, et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol 2008, 7:583-590. on behalf of the International LRRK2 Consortium.
4. Singleton A A new gene for Parkinson's disease: should we care?. Lancet Neurol 2015, 14:238-239.